Status: Recruiting
MacuTherm Performance Study in Patients With iAMD
The goal of this study is to demonstrate that photothermal therapy with the individually dosed treatment plan proposed by Macula Explorer delivered safely by Navilas® Laser System effectively improves the life of photoreceptors and reduces the progression of intermediate Age-related Macular Degeneration (iAMD) and preserves photoreceptors shown by Ellipsoid Zone Integrity (EZI). Participants will be randomized to either Treatment or Control Group. There will be 12 visits, monthly for the first 3 months, then quarterly until the end of the study after 2 years.
Participants needed: 240
Trial details
Age: 60-90Biological sex: AllType: InterventionalSponsor: OD-OS MacuTherm GmbHUpdated: Jun 4, 2026Locations: 4
Eligibility criteria
Male, female, or diverse [+9]
Presence of late-stage AMD, neovascular (nAMD, active or fibrotic) or geographic... [+17]